GemVax&KAEL Co.,Ltd 082270.KQ Stock
GemVax&KAEL Co.,Ltd Price Chart
GemVax&KAEL Co.,Ltd 082270.KQ Financial and Trading Overview
GemVax&KAEL Co.,Ltd stock price | 11200 KRW |
Previous Close | 14810 KRW |
Open | 14810 KRW |
Bid | 14800 KRW x 0 |
Ask | 14990 KRW x 0 |
Day's Range | 14730 - 15020 KRW |
52 Week Range | 11050 - 17440 KRW |
Volume | 59.83K KRW |
Avg. Volume | 195.61K KRW |
Market Cap | 527.24B KRW |
Beta (5Y Monthly) | 1.323885 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
082270.KQ Valuation Measures
Enterprise Value | 625B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.683508 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 7.923 |
Enterprise Value/EBITDA | 271.571 |
Trading Information
GemVax&KAEL Co.,Ltd Stock Price History
Beta (5Y Monthly) | 1.323885 |
52-Week Change | 7.31% |
S&P500 52-Week Change | 20.43% |
52 Week High | 17440 KRW |
52 Week Low | 11050 KRW |
50-Day Moving Average | 14444.6 KRW |
200-Day Moving Average | 13587.7 KRW |
082270.KQ Share Statistics
Avg. Volume (3 month) | 195.61K KRW |
Avg. Daily Volume (10-Days) | 139.15K KRW |
Shares Outstanding | 35.67M |
Float | 31.43M |
Short Ratio | N/A |
% Held by Insiders | 21.02% |
% Held by Institutions | 7.92% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | -8.17% |
Operating Margin (ttm) | -0.77% |
Gross Margin | 29.12% |
EBITDA Margin | 2.91% |
Management Effectiveness
Return on Assets (ttm) | -0.23% |
Return on Equity (ttm) | -4.38% |
Income Statement
Revenue (ttm) | 78.89B KRW |
Revenue Per Share (ttm) | 1995.94 KRW |
Quarterly Revenue Growth (yoy) | 54.20% |
Gross Profit (ttm) | 18.67B KRW |
EBITDA | 2.3B KRW |
Net Income Avi to Common (ttm) | -6447905280 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 18.86B KRW |
Total Cash Per Share (mrq) | 480.62 KRW |
Total Debt (mrq) | 7.45B KRW |
Total Debt/Equity (mrq) | 5.22 KRW |
Current Ratio (mrq) | 2.85 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -6114858496 KRW |
Levered Free Cash Flow (ttm) | -16199633920 KRW |
Profile of GemVax&KAEL Co.,Ltd
Country | South Korea |
State | N/A |
City | Daejeon |
Address | 58 Techno 11-ro |
ZIP | N/A |
Phone | 82 4 2931 6287 |
Website | https://www.gemvax.com |
Industry | |
Sector(s) | |
Full Time Employees | 158 |
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.
Q&A For GemVax&KAEL Co.,Ltd Stock
What is a current 082270.KQ stock price?
GemVax&KAEL Co.,Ltd 082270.KQ stock price today per share is 11200 KRW.
How to purchase GemVax&KAEL Co.,Ltd stock?
You can buy 082270.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GemVax&KAEL Co.,Ltd?
The stock symbol or ticker of GemVax&KAEL Co.,Ltd is 082270.KQ.
How many shares does GemVax&KAEL Co.,Ltd have in circulation?
The max supply of GemVax&KAEL Co.,Ltd shares is 39.42M.
What is GemVax&KAEL Co.,Ltd Price to Earnings Ratio (PE Ratio)?
GemVax&KAEL Co.,Ltd PE Ratio is now.
What was GemVax&KAEL Co.,Ltd earnings per share over the trailing 12 months (TTM)?
GemVax&KAEL Co.,Ltd EPS is 0 KRW over the trailing 12 months.